临床研究
纤维母细胞生长的血清水平Factor-23和磷酸钙肥胖准更年期妇女体内平衡
|
|
肥胖 |
控制 |
|
|
| 年龄(岁) |
55.4 (53.6 - -57.1) |
50.4 (46.0 - -54.7) |
|
| 体重(公斤) |
94.5 (90.6 - -98.3) |
62.4 (59.2 - -65.6) |
|
| BMI(公斤/米2) |
36.5 (35.1 - -37.9) |
23.5 (22.4 - -24.6) |
|
| 腰围(cm) |
106.7 (103.3 - -110.1) |
82.3 (78.3 - -86.4) |
|
| 脂肪组织含量(%) |
49.6 (47.8 - -51.3) |
35.2 (32.3 - -38.2) |
|
| BMD L2- l4(克/厘米2) |
1.196 (1.133 - -1.259) |
1.035 (0.930 - -1.140) |
|
| BMD近端股骨(g / cm2) |
1.026 (0.976 - -1.076) |
0.858 (0.808 - -0.909) |
|
| BMC L2- l4(克/厘米) |
65.0 (60.7 - -69.3) |
56.4 (51.1 - -61.7) |
|
| BMC近端股骨(g / cm) |
4.87 (4.58 - -5.16) |
4.23 (3.81 - -4.64) |
|
| 肌酐(mg / dL) |
0.64 (0.61 - -0.67) |
0.66 (0.61 - -0.71) |
|
| 表皮生长因子受体(毫升/分钟) |
97.4 (94.4 - -100.3) |
99.5 (92.7 - -106.3) |
|
| 总钙(更易/ L) |
2.22 (2.18 - -2.25) |
2.19 (2.13 - -2.25) |
|
| 磷(更易/ L) |
1.04 (1.00 - -1.08) |
1.15 (1.09 - -1.21) |
|
| 25 (OH) D3(ng / mL) |
30.2 (26.2 - -34.2) |
43.5 (34.8 - -52.1) |
|
| 骨钙素(ng / mL) |
19.1 (17.4 - -20.9) |
24.0 (20.4 - -27.6) |
|
| iPTH (pg / mL) |
47.3 (42.2 - -52.3) |
35.4 (30.4 - -40.4) |
|
| CTX1(ng / mL) |
0.24 (0.21 - -0.27) |
0.28 (0.21 - -0.35) |
|
| iFGF-23 (ng / mL) |
9.14 (7.12 - -11.15) |
6.44 (5.70 - -7.18) |
|
|
|
甲状旁腺素:甲状旁腺激素;CTX1:胶原蛋白c端端肽的I型;体重指数:体重、BMD:骨矿物质密度,BMC:骨矿物质含量、iFGF-23:完整的成纤维细胞生长因子23,表皮生长因子受体:估计肾小球滤过率。
|
